No Data
No Data
Express News | Adage Capital Management, L.p. Reports 7.12% Passive Stake in Aligos Therapeutics as of Sept 30 - SEC Filing
Express News | Aligos Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 60%
Express News | Aligos Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results. HC Wainwright & Co. Reiterated a Buy Rating on the Stock
Aligos Therapeutics Participates in a Conference Call With Jefferies
Aligos Therapeutics Analyst Ratings
H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $75
No Data
No Data
RIPPER OP :